Our impact
Our mission is to improve lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications.
Key to this, has been our community powered drive to fundamentally transform the way governments understand and invest in T1D. This has produced nearly half a billion dollars of new investment in T1D in Australia in the last 10 years.
As a direct result of this program, JDRF has helped deliver a T1D-focused policy in every election cycle since 2004, across both parties in government. The policies are listed below.
2004
$30m for the JDRF Islet Transplantation Program.
2007
$20m (to date) for the JDRF T1D Insulin Pump Program.
2010
$5m to establish the Type 1 Diabetes Clinical Research Network (T1DCRN).
2013
$35m for the extension of the T1DCRN.
2016
$54m for access to life changing T1D monitoring technology, continuous glucose monitors (CGMs).
2018
$154m to extend access to CGMs.
2018
$125 million for investment in translational diabetes and cardiovascular disease research.
2019
$56 million for type 1 diabetes research sector, including further extension of the T1DCRN.
In the last financial year, our numbers highlight the impact and progression that JDRF in partnership with the community, has delivered.
$13 million
Invested in research
52
Studies and clinical trials funded
2400+
People involved in clinical trials
458,440
Needles avoided via the Insulin Pump Program
17.6 million
Finger pricks avoided via JDRF’s advocacy efforts that helped deliver the Government’s Continuous Glucose Monitoring Funding Initiative
960
Support and education packs (KIDSACs) delivered to newly diagnosed families
I am interested in hearing more about…